Table 1.
Baseline Characteristics of Patients in the Derivation Cohort With and Without Obstructive CAD
|
With Obstructive CAD (≥70% Stenosis) (n=421) |
Without Obstructive CAD (70% Stenosis) (n=215) | P Value | |
|---|---|---|---|
| Demographics | |||
| Age, y (SD) | 67.4 (11.5) | 64.2 (11.7) | 0.001 |
| Men, No. (%) | 330 (78.4) | 125 (58.1) | <0.001 |
| Body mass index (SD) | 29.2 (5.4) | 28.8 (6.3) | 0.41 |
| Medical history, No. (%) | |||
| Hypertension | 331 (78.6) | 143 (66.5) | 0.001 |
| Type 1/type 2 diabetes mellitus | 132 (31.4) | 32 (14.9) | <0.001 |
| Previous coronary percutaneous intervention | 180 (42.8) | 6 (2.8) | <0.001 |
| Laboratory tests | |||
| Adiponectin, μg/mL | 3.4 (2.2–5.1) | 4.5 (2.9–7.2) | <0.001 |
| KIM‐1, ng/mL | 0.04 (0.01–0.07) | 0.03 (0.01–0.05) | <0.001 |
| hs‐cTnI, ng/L | 9.7 (4–35.7) | 5.9 (3–13.6) | <0.001 |
Values are expressed as mean and standard deviation unless otherwise indicated. CAD indicates coronary artery disease; hs‐cTnI, high‐sensitivity cardiac troponin I; and KIM‐1; kidney injury molecule‐1.